Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide's tightly controlled "comeback".

L H Calabrese1

  • 1Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, USA.

Cleveland Clinic Journal of Medicine
|March 18, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Intersection of COVID-19 and Autoimmunity: What is Our Current Understanding?

Pathogens & immunity·2021
Same author

Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma.

Clinical and experimental dermatology·2018
Same author

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same author

Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity.

RMD open·2017
Same author

Menstrual Abnormalities, Nutritional Patterns, and Body Composition in Female Classical Ballet Dancers.

The Physician and sportsmedicine·2016
Same author

AIDS and Athletes.

The Physician and sportsmedicine·2016
Same journal

A 20-year-old woman with a 9-year history of shortness of breath.

Cleveland Clinic journal of medicine·2026
Same journal

A 70-year-old man with lower-extremity weakness and falls.

Cleveland Clinic journal of medicine·2026
Same journal

Treatment-refractory hypothyroidism: Don't just increase the dose.

Cleveland Clinic journal of medicine·2026
Same journal

In Reply: Beyond histologic improvement in MASH.

Cleveland Clinic journal of medicine·2026
Same journal

Comfort care: Creating a plan for hospitalized patients and their families.

Cleveland Clinic journal of medicine·2026
Same journal

Localized dead bone, a potential hint to an underlying condition.

Cleveland Clinic journal of medicine·2026
See all related articles

Thalidomide, an anti-inflammatory drug, shows potential for treating infectious and autoimmune diseases. However, its use requires strict safety measures due to potential risks.

Area of Science:

  • Immunology
  • Pharmacology
  • Infectious Diseases

Background:

  • Thalidomide possesses notable anti-inflammatory properties.
  • Existing research suggests thalidomide's therapeutic potential in various medical conditions.

Purpose of the Study:

  • To explore the anti-inflammatory effects of thalidomide.
  • To evaluate the promise of thalidomide in treating infectious and autoimmune diseases.

Main Methods:

  • Literature review of thalidomide's pharmacological actions.
  • Analysis of clinical data regarding thalidomide efficacy and safety.

Main Results:

  • Thalidomide demonstrates significant anti-inflammatory activity.
  • The drug shows promise for treating a range of infectious and autoimmune disorders.

Related Experiment Videos

Conclusions:

  • Thalidomide is a promising therapeutic agent for inflammatory conditions.
  • Strict precautions are essential for the safe administration of thalidomide.